Rivaroxaban Impurity 85 CAS 19213-72-0

Description

Compared with other compounds in its class, the molecular weight of 140.14 g/mol gives Rivaroxaban Impurity 85 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Rivaroxaban Impurity 85 (CAS 19213-72-0), a pharmacopoeial impurity reference standard (molecular formula C6H8N2O2, MW 140.14 g/mol) used for the identification and quantification of trace impurities in APIs.

Rivaroxaban Impurity 85 (C6H8N2O2) contains an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. It is notably hygroscopic, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Rivaroxaban Impurity 85 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com